← The Record Behind the Decision
Episode 2 · CAPA Effectiveness · 20 min 7 sec
CAPA Effectiveness: Two Warning Letters, One Failure
Samantha and Alex examine two November FDA warning letters and what makes a CAPA record hold up — the shared quality-unit failure, the CAPA pattern, and the six questions a CAPA record has to answer.
With Samantha and Alex ·
What did this episode raise for you?
Ask about this episode or your situation…
“My CAPA has been open 11 months. Is that a problem?”
The assistant is still loading. Use the Talk to Our Assistant button at the bottom right of this page.
Examine the decision
CAPA Effectiveness Case File
A completed, clearly labeled fictional worked example showing how evidence, judgment, remaining risk, and authorization fit together behind one CAPA closure—and where questions can remain.
Examine the Case File — $149Working on your own CAPA? View the CAPA Sufficiency Review — $39
The Decision Tool is a structured review of your own records. It is not a compliance determination, does not make, approve, or authorize a regulated Quality decision, and does not predict inspection outcomes.
Further reading
-
Article · 9 min read
Beyond Documentation: Using Intelligent Systems to Examine GMP Decisions
A CAPA can be complete on paper and still leave open why the evidence was sufficient to justify closure. An interactive case examines the reasoning, not only the record.
Read the article -
Article · 7 min read
The Business of Compliance: What Quality Leaders Are Really Asking the Business to Fund
Quality funding decisions shape release confidence, supply resilience, and the consequences leadership accepts.
Read the article -
Next episode · Episode 3
The Deviation Was Closed. The Problem Wasn't.
Samantha and Alex examine two FDA warning letters from September 2026, Fresenius Kabi and Baxter, and the deviation closures that looked complete until FDA read them.
Listen · 21 min 8 sec